Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

Denoised MDS-UPDRS part-III scores yield new patterns of progression heterogeneity in early stage Parkinson's disease.

Koss JD, Tinaz S, Tagare HD.

NPJ Parkinsons Dis · 2026-06-11

DOI: 10.1038/s41531-026-01369-wPMID: 42277044

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Identifing two distinct cortical progression subtypes of Parkinson's disease through multimodal neuroimaging.

Yu Q, Guan X, Wu J, Sun X, Chen Q, Yu D, Liu L, Kuang G, Li J, Hu X, Cheung H, Xu F, Gong J, Du F, Lan X, Xiong N, Wang J.

Eur J Nucl Med Mol Imaging · 2026-06-10

DOI: 10.1007/s00259-026-07975-3PMID: 42268403

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

DJ-1 in the Neuro-cutaneous Aging Axis: Unifying Pathways of Parkinson's Disease Neurodegeneration, Progression, and Redox-Based Therapeutic Strategies for Healthy Longevity.

Sivalingam AM.

Mol Neurobiol · 2026-06-08

DOI: 10.1007/s12035-026-05981-yPMID: 42257810

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Spatiotemporal Progression Patterns of Striatal Dopamine Depletion and Cerebral Hypoperfusion in Parkinson's Disease.

Sun Y, Choi Y, Park CW, Na HK, Lee HS, Kim YJ, Sohn YH, Lee PH, Lee J, Chung SJ.

Mov Disord · 2026-06-08

DOI: 10.1002/mds.70398PMID: 42261072

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Evidence for exponential progression in advanced Parkinson's disease: retrospective analysis of a prospective cohort study.

Yener SM, Ding C, Ganesvaran G, Alty JE, Clissold BG, McColl CD, Reardon KA, Schiff M, Kempster PA.

Front Neurol · 2026-06-05

DOI: 10.3389/fneur.2026.1788633PMID: 42327801

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Progression in Parkinson's Disease.

Irmady K, Przedborski S.

Cold Spring Harb Perspect Med · 2026-06-01

DOI: 10.1101/cshperspect.a041641PMID: 39929733

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Correction: Zhang et al. Caudate-Centric Triphasic Network Reconfiguration Characterizes the Early Progression of Cognitive Impairment in Parkinson's Disease: A Simultaneous PET/fMRI Study. Journal of Integrative Neuroscience. 2026; 25(2): 46634.

Zhang W, Li G, Mao F, Zhao H, Zhao L, Liang L, Guo Y, Sun C, Yang Y, Wang X, Luo X.

J Integr Neurosci · 2026-06-01

DOI: 10.31083/jin55311PMID: 42411442

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Changes in Saccadic Hypometria over Time to Monitor Parkinson's Disease Progression.

Ben-Ami E, Raveh E, Harpaz E, Riklin I, Band T, Gurevich T, Alcalay RN, Mir P, Tosin MHS, Goetz CG, Rascol O.

Pharmaceut Med · 2026-05-30

DOI: 10.1007/s40290-026-00612-2PMID: 42217107

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Effects of levodopa on the motor reserve network change with progression of Parkinson's disease.

Rong D, Huang P, Yan L, Yang J, Liu W, Shen Y, Zhang W, Yu M, Liu W.

Prog Neuropsychopharmacol Biol Psychiatry · 2026-05-25

DOI: 10.1016/j.pnpbp.2026.111755PMID: 42190988

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Tracking the longitudinal progression of Bradykinesia in Parkinson's disease from videos using VisionMD.

Acevedo G, Lange F, Wong JK, Vaillancourt DE, Guarin DL.

J Parkinsons Dis · 2026-05-22

DOI: 10.1177/1877718x261448385PMID: 42170718

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.

Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey CS, Lafontant DE, Xiao Y, Tanner CM, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Galasko D, Picillo M, Siderowf A, Tropea TF, Simuni T, Marek K, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-05-18

DOI: 10.1002/ana.78248PMID: 42152134

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Amyloid status as a moderator of the association between physical activity and progression of Parkinson's disease.

Lee MJ, Pak K, Kim M, Lee JH.

Parkinsonism Relat Disord · 2026-05-18

DOI: 10.1016/j.parkreldis.2026.108361PMID: 42214116

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

1.057 makale bulundu

Denoised MDS-UPDRS part-III scores yield new patterns of progression heterogeneity in early stage Parkinson's disease.

Identifing two distinct cortical progression subtypes of Parkinson's disease through multimodal neuroimaging.

DJ-1 in the Neuro-cutaneous Aging Axis: Unifying Pathways of Parkinson's Disease Neurodegeneration, Progression, and Redox-Based Therapeutic Strategies for Healthy Longevity.

Spatiotemporal Progression Patterns of Striatal Dopamine Depletion and Cerebral Hypoperfusion in Parkinson's Disease.

Evidence for exponential progression in advanced Parkinson's disease: retrospective analysis of a prospective cohort study.

Progression in Parkinson's Disease.

Correction: Zhang et al. Caudate-Centric Triphasic Network Reconfiguration Characterizes the Early Progression of Cognitive Impairment in Parkinson's Disease: A Simultaneous PET/fMRI Study. Journal of Integrative Neuroscience. 2026; 25(2): 46634.

Changes in Saccadic Hypometria over Time to Monitor Parkinson's Disease Progression.

Effects of levodopa on the motor reserve network change with progression of Parkinson's disease.

Tracking the longitudinal progression of Bradykinesia in Parkinson's disease from videos using VisionMD.

Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.

Amyloid status as a moderator of the association between physical activity and progression of Parkinson's disease.

Filtreler